KZR earnings: a positive outcome, +13.1%

On November 10, 2022, Kezar Life Sciences, Inc. reached its earnings. The result was a positive outcome, and the stock moved +13.1% in the window around the event. It had already run -11.4% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.